Literature DB >> 23201375

Extracorporeal shock wave lithotripsy is effective in treating single melamine induced urolithiasis in infants and young children.

Jianye Jia1, Xiaowei Shen, Liya Wang, Tiejun Zhang, Maosheng Xu, Xiaoliang Fang, Guofeng Xu, Chen Qian, Yeming Wu, Hongquan Geng.   

Abstract

PURPOSE: We evaluated the safety and efficacy of extracorporeal shock wave lithotripsy in the treatment of single melamine induced urolithiasis in infants and young children.
MATERIALS AND METHODS: A total of 189 infants and young children with single melamine induced urolithiasis were referred to our center for treatment with extracorporeal shock wave lithotripsy between March 2009 and July 2010. Location of the calculus was proximal ureteral in 17 patients, mid ureteral in 5, distal ureteral in 26 and kidney in 141. Stone size ranged from 3.8 to 25 mm (mean ± SD 9.79 ± 3.83).
RESULTS: All patients underwent extracorporeal shock wave lithotripsy using the same device with an energy ranging from 8 to 12 kV. Stone-free rate was 97.88%, clinically insignificant residual fragment rate was 1.59% and repeat treatment rate was 2.65%. A total of 180 patients (95.24%) required only 1 lithotripsy session and 5 (2.65%) required 2 sessions. Mean ± SD number of shock waves delivered per session was 580.36 ± 190.69 (range 65 to 950). Extracorporeal shock wave lithotripsy failed to fragment stones in only 1 infant, who had a proximal ureteral stone. A total of 181 specimens were collected and analyzed by infrared spectrum, with results demonstrating that the main composition was uric acid and melamine. All patients were followed for a mean of 28 months (range 20 to 36). No severe complication, such as renal subcapsular hemorrhage, hypertension, kidney rupture or lung injury, was observed.
CONCLUSIONS: Extracorporeal shock wave lithotripsy with low energy can effectively disintegrate melamine induced calculi. This approach has become our preferred method for treating single melamine induced urolithiasis in infants and young children.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201375     DOI: 10.1016/j.juro.2012.11.109

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis.

Authors:  Zhengyao Song; Chen Jin; Zichen Bian; Chaozhao Liang
Journal:  Mol Cell Biochem       Date:  2021-01-25       Impact factor: 3.396

2.  Correlative investigation between routine clinical parameters of dual-energy computed tomography and the outcomes of extracorporeal shock wave lithotripsy in children with urolithiasis: a retrospective study.

Authors:  Beiwu Tu; Jianye Jia; Lengwei Yu; Huimin Li; Dengbin Wang
Journal:  Abdom Radiol (NY)       Date:  2021-06-10

3.  Acute kidney injury caused by ceftriaxone-induced urolithiasis in children: a single-institutional experience in diagnosis, treatment and follow-up.

Authors:  Xiaowei Shen; Wang Liu; Xiaoliang Fang; Jianye Jia; Houwei Lin; Maosheng Xu; Hongquan Geng
Journal:  Int Urol Nephrol       Date:  2014-05-31       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.